Drug Profile
Research programme: DNA vaccines - IGXBio
Alternative Names: GenePro; HIV DNA vaccine - ImmunoGenetix; Δ4SHIVku2Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator ImmunoGenetix Therapeutics
- Class AIDS vaccines; Viral hepatitis vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis C; HIV infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Hepatitis-C in USA (Parenteral)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Hepatitis-C(Prevention) in USA (Parenteral)
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections in USA (Parenteral)